Key result
Incremental intravenous labetalol achieves smooth blood pressure reduction in ~63% of severely hypertensive patients.
Answers are grounded in this paper and cite their sources.
Labetalol was given by incremental intravenous infusion to nineteen severely hypertensive patients, of whom nine were refractory to previous oral antihypertensive therapy. 2. Smooth reduction of arterial pressure was achieved in twelve subjects; one remained resistant to labetalol up to 160 mg/h; a sudden fall in pressure occurred in the remaining six. No serious complications were encountered. Blood pressure control was accompanied by slight byt significant reduction in heart rate and in plasma angiotensin II and aldosterone concentrations. 3. The administration of labetalol in this way appears to be a useful technique in patients requiring rapid reduction of arterial pressure, although close and continuous supervision is necessary.
No takes yet. Share an insight, caveat, or question.
Cummings et al. (1979) studied severe hypertension (n=19). Labetalol was evaluated on Smooth reduction of arterial pressure. Incremental intravenous infusion of labetalol achieved smooth reduction of arterial pressure in 63.2% of severely hypertensive patients, with no serious complications encountered.
Synapse has enriched 10 related papers. Consider them for comparative context: